Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Breakthrough drug to regrow teeth set for human trials – SUCH TV

[ad_1]

Imagine a world where tooth loss is a thing of the past. Japanese researchers have made a groundbreaking discovery that could make this a reality. A revolutionary drug that regrows teeth has shown promising results in animals and is now set for human trials in September.

The drug, developed by Kyoto University Hospital, has successfully regenerated teeth in ferrets and mice without significant side effects. Lead researcher Katsu Takahashi’s team aims to help those suffering from tooth loss or absence, a condition that affects millions worldwide.

The human trial will involve 30 males aged 30-64 who are missing at least one molar. The intravenous treatment will be tested for its efficacy on human dentition. If successful, the drug could be available commercially as early as 2030.

The medicine works by blocking a protein that suppresses tooth growth, allowing new bone to generate. This breakthrough could bring hope to those with congenital tooth deficiency, partial edentulism, or environmental tooth loss.

For people like [insert example], who have struggled with tooth loss for years, this drug could be a game-changer. “I’ve tried various treatments, but nothing has worked. The thought of regrowing my teeth is a dream come true,” they said.

The trial is a beacon of hope for those seeking a permanent solution to tooth loss. With its potential to transform lives, this drug could revolutionize the field of dentistry forever.

[ad_2]

Source link